NISPA

Nijmegen Institute for Scientist-Practitioners in Addiction

Publicaties

Resultaten gevonden: 369
Auteur Titel [ Jaar(Asc)]
2019
Jokubonis D, Adomaitiene V, Leleikiene A, Baltaityte L, Dirzius E, De Jong CAJ.  2019.  How to integrate addiction medicine in psychiatry training: results of an experiment with two educational methods. Open Review of Educational Research. 6(1)
van Rijswijk SM, van Beek MHCT, Schoof GM, Schene AH, Steegers M, Schellekens AFA.  2019.  Iatrogenic opioid use disorder, chronic pain and psychiatric comorbidity: A systematic review. Gen Hosp Psychiatry. 59:37-50.
Klaassen R., van Delden R., VanDerNagel JEL, Kamp M., Thio B., Heylen D..  2019.  In body experiences: Persuasion by doing. CEUR workshop proceedings. 2340
Bruijnen CJWH, Jansen M, Dijkstra BAG, Walvoort SJW, Lugtmeijer S, Markus W, de Jong CAJ, Kessels RPC.  2019.  The Montreal Cognitive Assessment (MoCA) as a cognitive screen in addiction health care: A validation study for clinical practice. Journal of Substance Use. 24(1)
Schellekens AFA, Vanderschuren L.  2019.  Neurobiologie van verslaving. Handboek Verslaving.
Van de Wijer L, Garcia LP, Hanswijk SI, Rando J, Middelman A, Heine RTer, de Mast Q, Martens GJM, Van der Ven AJAM, Kolk SM et al..  2019.  Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent model. Transl Psychiatry. 9(1):84.
Van de Wijer L, Mchaile DN, de Mast Q, Mmbaga BT, Rommelse NNJ, Duinmaijer A, Van der Ven AJAM, Schellekens AFA, Kinabo GD.  2019.  Neuropsychiatric symptoms in Tanzanian HIV-infected children receiving long-term efavirenz treatment: a multicentre, cross-sectional, observational study. Lancet HIV. 6(4):e250-e258.
Ebenau A, Dijkstra BAG, Huurne CTer, Hasselaar J, Vissers K, Groot M.  2019.  Palliative care for people with substance use disorder and multiple problems: a qualitative study on experiences of patients and proxies. BMC Palliat Care. 18(1):56.
Bruijnen CJWH, Dijkstra BAG, Walvoort SJW, Markus W, VanDerNagel JEL, Kessels RPC, de Jong CAJ.  2019.  Prevalence of cognitive impairment in patients with substance use disorder. The Authors Drug and Alcohol Review .
Bruijnen CJWH, Dijkstra BAG, Walvoort SJW, Markus W, VanDerNagel JEL, Kessels RPC, DeJong CAJ.  2019.  Prevalence of cognitive impairment in patients with substance use disorder. Drug Alcohol Rev. 38(4):435-442.
Beurmanjer H, Asperslag EM, Oliemeulen L, Goudriaan AE, De Jong CAJ, Schellekens AFA, Dijkstra BAG.  2019.  A Qualitative Approach in Understanding Illness Perception and Treatment Needs in Patients with Gamma Hydroxybutyrate Use Disorder.. Eur Addict Res. 25(5):248-255.
Bruijnen CJWH, Young SY, Marx M, Seedat S.  2019.  Social anxiety disorder and childhood trauma in the context of anxiety (behavioural inhibition), impulsivity (behavioural activation) and quality of life. South African Journal of Psychiatry. 25:1-7.
van Lier HG, Pieterse ME, Garde A, Postel MG, de Haan H.A., Vollenbroek-Hutten MMR, Schraagen JMaarten, Noordzij ML.  2019.  A standardized validity assessment protocol for physiological signals from wearable technology: Methodological underpinnings and an application to the E4 biosensor. Behav Res Methods.
VanDerNagel JEL, van Duijvenbode N, Didden R.  2019.  Substance use disorders. Handbook of intellectual disabilities – Integrating theory, research, and practice.
van Duijvenbode N, VanDerNagel JEL.  2019.  A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability. Eur Addict Res. :1-20.
van Esch AMJ, Fest A, Hoffland BS, Janzing JGE, Steens SCA, Esselink RAJ, Schellekens AFA.  2019.  Toxic Leukoencephalopathy Presenting as Lethal Catatonia. J Addict Med. 13(3):241-244.
2018
Beurmanjer H, Kamal RM, de Jong CAJ, Dijkstra BAG, Schellekens AFA.  2018.  Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.. CNS Drugs. 32(5):437-442.
Leskauskas D, Adomaitienė V, De Jong CAJ, Vorevičiūtė B, Juknaitė R.  2018.  Changes over time in Lithuanian schoolchildren's attitudes toward addictive behaviors: Promoting and preventing factors.. PLoS One. 13(12):e0208481.
Duijvenbode vanN, Didden R, VanDerNagel JEL, Korzilius HPLM, Engels RCME.  2018.  Cognitive deficits in problematic drinkers with and without mild to borderline intellectual disability. Journal of Intellectual Disabilities. 22(1):5-17.
van Erp N, Verbrugge C.  2018.  Factsheet Herstel en Verslaving. Verslavingskunde Nederland GGZ1830-01.
van Elsué N, Crunelle C, Verbrugge C, van Baarle K, Rodriquez A, Neels H, Yegles M.  2018.  Gammahydroxybutyrate in hair of non-GHB and repeated GHB users: A new and optimized method.. Forensic Science International.
Soe-Agnie SE, Paap MCS, VanDerNagel JEL, Nijman HJM, de Jong CAJ.  2018.  The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review. Psychiatry Research. 259:412-421.
Soe-Agnie SE, Paap MCS, VanDerNagel JEL, Nijman HJM, de Jong CAJ.  2018.  The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review.. Psychiatry Res. 259:412-421.
Knuijver T, Belgers M, Markus W, Verkes R-J, van Oosteren T, Schellekens AFA.  2018.  Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence. J Clin Psychopharmacol. 38(6):646-648.
Verbrugge C, Stollenga M, Hollander.T den, Dijkstra B.  2018.  Herstelsteun. Toepassingen in praktijk van de verslavingszorg.Ingediend.. Handboek Steunend Relationeel Handelen.

Pagina's